Icosapent Ethyl Reduces Atherogenic Markers in High-Risk Statin-Treated Patients With Stage 3 Chronic Kidney Disease and High Triglycerides
Postgraduate Medicine - United Kingdom
doi 10.1080/00325481.2019.1643633
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 25, 2019
Authors
Publisher
Informa UK Limited